Stevanato Group S.p.A STVN
NYSE STVN
$20.92 +0.68 (+3.36%)
As of: Sep 10, 2026 · 3:59 PM EDT

Stevanato Group S.p.A (STVN) Total Non-Current Liabilities (2020 - 2026)

Stevanato Group S.p.A's (STVN) quarterly Total Non-Current Liabilities came in at -$89.3 million in Q2 2026, down 0.98% year-over-year from -$90.1 million in Q2 2025, and up 0.72% quarter-over-quarter from -$89.9 million in Q1 2026.

Analysis

Stevanato Group S.p.A (STVN) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

Stevanato Group S.p.A (STVN) has reported Total Non-Current Liabilities for 7 consecutive years, with -$89.3 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Total Non-Current Liabilities fell 0.98% year-over-year to -$89.3 million in Q2 2026; TTM through Jun 2026 was -$89.3 million, a 0.98% decrease from a year earlier, with the FY2025 full-year figure at -$87.8 million, down 118.38% from the prior year.
  • Total Non-Current Liabilities was -$89.3 million for Q2 2026 at Stevanato Group S.p.A, up from -$89.9 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $477.6 million in Q4 2024 and troughed at -$91.2 million in Q3 2025.
  • A 5-year average of -$2.3 million and a median of -$78.7 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • Across the five-year window, Total Non-Current Liabilities soared 90.99% in 2023 and sank 118.38% in 2025, its largest moves.
  • Over 5 years, Total Non-Current Liabilities stood at $205.4 million in 2022, then soared by 90.99% to $392.2 million in 2023, then gained by 21.77% to $477.6 million in 2024, then slumped by 118.38% to -$87.8 million in 2025, then declined by 1.71% to -$89.3 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at -$89.3 million (Q2 2026), -$89.9 million (Q1 2026), and -$87.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Becton Dickinson 48.41 Bn 47.55 Bn 2.32 Bn 23.92 Bn
2 Medline 27.78 Bn 25.10 Bn 2.22 Bn 17.56 Bn
3 West Pharmaceutical Services 24.42 Bn 23.98 Bn 329.20 Mn 996.30 Mn
4 Baxter International 12.49 Bn 10.34 Bn 1.03 Bn 12.41 Bn
5 Stevanato Group S.p.A 5.70 Bn 5.59 Bn 100.91 Mn -89.27 Mn
6 Acme United 235.29 Mn 230.25 Mn 26.69 Mn 75.19 Mn
7 Rockwell Medical 31.39 Mn 6.60 Mn 3.24 Mn -
8 Retractable Technologies 21.15 Mn -18.72 Mn 190,852.00 13.70 Mn
9 United Health Products 8.85 Mn 8.82 Mn - 4.54 Mn
10 Cuprina Holdings (Cayman) 7.88 Mn 4.76 Mn - 333,758.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -89.27 Mn
Mar 31, 2026 -89.91 Mn
Dec 31, 2025 -87.77 Mn
Sep 30, 2025 -91.19 Mn
Jun 30, 2025 -88.41 Mn
Mar 31, 2025 -86.99 Mn
Dec 31, 2024 477.62 Mn
Sep 30, 2024 -81.38 Mn
Jun 30, 2024 -78.83 Mn
Mar 31, 2024 -78.65 Mn
Dec 31, 2023 392.23 Mn
Sep 30, 2023 -80.45 Mn
Jun 30, 2023 -74.05 Mn
Mar 31, 2023 -57.32 Mn
Dec 31, 2022 205.36 Mn
Sep 30, 2022 -51.02 Mn
Jun 30, 2022 -39.27 Mn
Mar 31, 2022 -41.41 Mn
Dec 31, 2021 272.91 Mn
Sep 30, 2021 315.78 Mn